Talk:Brilacidin

Pharmacology Low‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Low	This article has been rated as Low-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Improvement

Latest comment: 9 years ago1 comment1 person in discussion

I would suggest to improve the article and to give it more attention as this new drug/class of antibiotics proved to have potent and rapid bactericidal activity against a good number of disease associated bacteria, doesn't develop resistance and it has passed numerous trials. Interestingly, Teixobactin has got an article in Nature and is more famous and hyped, however it is far behind in in-vivo trials. Sources such as http://www.thestreet.com/story/11696242/2/www.thestreet.com/story/12004957/1/cramer-jc-penney-goes-from-bad-to-dire.html might be used and peer-reviewed publications should be available too. Dmatteng (talk) 05:32, 1 April 2015 (UTC)Reply

Latest comment: 8 years ago1 comment1 person in discussion

It's described as an arylamide = aryl+amide - Seems to have 3 aromatic rings (2 fluorinated) between 4 amide groups. But what are the two ends called ? - Rod57 (talk) 04:05, 7 January 2016 (UTC)Reply